Neoplasm
RecruitingStudy of ALE.
Study of ALE.
Spain- Participants:18–64 years · 65+ years
- Substances:ALE.P03
- Sponsor:Alentis Therapeutics AG
Rare diseases
Investigational molecules
Locations
Back to Spain3 744 clinical trials in Terrassa, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of ALE.
SpainA Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer
SpainA Study Comparing GDC-4198 Alone and with Giredestrant versus Abemaciclib with Giredestrant for Advanced Breast Cancer After Previous CDK4/6 Treatment
Spain
SpainStudy of AEF0217 compared to placebo for improving behavior and thinking skills in adults and older adolescents with Down syndrome
SpainStudy of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk
SpainA Study of JNJ-78278343 Compared to Placebo for Patients with Advanced Prostate Cancer That No Longer Responds to Hormone Treatment
SpainA Study of Amivantamab and Lazertinib for Adults with EGFR-Mutated Advanced or Metastatic Non-Small Cell Lung Cancer
SpainA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
SpainA Study of Teplizumab Compared to Placebo for Blood Sugar Control in Children and Young Adults Aged 1 to 25 Years with Newly Diagnosed Type 1 Diabetes
SpainA Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment
SpainA study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on multiple myeloma, breast cancer, and prostate cancer treatments. Innovative combination therapies and targeted approaches are being evaluated for improved patient outcomes.
Studies include novel immunotherapy combinations and precision medicine approaches.
Clinical trials investigating immunotherapy treatments for various allergic conditions, including advanced research in rhinitis and rhinoconjunctivitis management.
Focus on developing targeted allergen-specific treatments for improved quality of life.
Innovative research into Parkinson's Disease and Alzheimer's Disease, exploring new therapeutic approaches and disease-modifying treatments.
Studies emphasize long-term safety and efficacy of novel therapeutic agents.
Tell us about your condition – we search every trial in Europe and connect you with the right site.